TBC. Final Report Final Report - achievements and final outcomes against the agreed activity work plan as set out in item E.4. TBC Financial Acquittal Report Financial declaration as set out in item E.3. TBC
TBC. In the event of a Change in Control of either of the TBC Partners, ICOS-LP shall [ * ], except (a) all accrued obligations shall survive, (b) the provisions of Sections 2.7, 3.2.3 and 5.3 and Articles 10 and 11 shall survive, (c) the Endothelin License Agreement will not terminate, and (d) Article 6 of the Research and Development Service Agreement shall survive but shall not operate as to any future developments, inventions or discoveries.
TBC. This information is to be quantified. It will include: HIE’s discretionary cash budget for the 3 area offices; HIE projects over the period including strategic projects that will impact in the Highland area; Highland Council’s budget for Business Gateway and Employability.
TBC. 30.1 The delivery date of the goods and services is: goods and services delivery date 1 TBC TBC 2 TBC TBC 3 TBC TBC
TBC. TBC shall invoice MOS weekly for the Base Retainer and approved out-of-pocket fees incurred in the prior week. The Base Retainer and any fees which are not subject to a bona fide good faith dispute shall be paid within thirty (30) days of receipt of the invoice. TBC shall invoice MOS monthly for the call center fees incurred in the prior month. Call center fees which are not subject to a bona fide good faith dispute shall be paid within ten (10) business days of receipt of the invoice. All invoiced amounts shall be deemed valid and undisputed unless MOS notifies TBC of a dispute within ten (10) business days from the date of MOS' receipt of the applicable invoice.
TBC. The parties contemplate that TBC shall be responsible for the discovery and origination of Products, the conduct of research outside of the Territory regarding the development of the Products, clinical trials outside of the Territory regarding the Products, and Patent filing, maintenance and prosecution regarding the Products in all geographic areas. Any research and development information generated by TBC's Receptor Antagonist and Selectin Antagonist Programs will be shared without cost to LG Chem.
TBC. Commencement Date 1.1 and 3.1 The date this Agreement is signed by the last Party. Activity Start Date 1.1 and 3 1 April 2017 Activity End Date 1.1 and 4.1 (b) (iii) 30 June 2021 Agreement Period 1.1 and 15.4 The period from the Commencement Date to the date DFAT accepts the final report provided in accordance with Part B – Clause 15.4.
TBC. 30.1 The delivery date of the goods and services is: goods and services delivery date 1 Mobile Equipment TBA 2 Lifting Equipment TBA
